Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
san francisco blog main
deals
gilead sciences
hepatitis b
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
startups
abbvie
allergan aesthetics
alnylam pharmaceuticals
alzheimer's disease
amgen
astrazeneca
athira pharma
attralus
beijing
biobucks
biontech
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
brii bio
brii biosciences
calistoga pharmaceuticals
cancer
cancer drugs
car-t immunotherapy
checkpoint inhibitors
chiesi farmaceutici
china
cholestatic liver diseases
What
drug
3
×
pipeline
3
×
gilead
million
sciences
acquisitions
adding
adds
alliance
areas
bets
biggest
bio
biosciences
bio’s
boost
brii
build
buy
cancer
ceo
company’s
daniel
debut
disease
dyne’s
earlier
expensive
far
hepatitis
infectious
launched
medicines
microbiome
mission
moves
new
openly
o’day
paying
Language
unset
Current search:
pipeline
×
drug
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango